Anti-Mensing Bill Could Topple FDA's Generics Framework
A proposed bill that would allow generic-drug makers to change their own safety labels — an effort to open generics companies to failure-to-warn suits after the Supreme Court found last year...To view the full article, register now.
Already a subscriber? Click here to view full article